Following recent findings on the dual benefits of GLP‑1 medications—a popular class for weight loss and diabetes management—men across the U.S. are increasingly adopting a suite of health-tracking technologies. Sales of fitness wearables, continuous glucose monitors (CGMs), and hormone-tracking apps have spiked, signaling a shift toward comprehensive wellness strategies rather than single-focus health trends.
Leading the charge are CGMs like Abbott’s FreeStyle Libre series, which saw a 21.4% year-over-year sales jump in Q2 to $1.9 billion—a boost directly tied to rising public interest in metabolic health and non-diabetic usage. Even as GLP‑1 drugs initially raised speculation they might diminish demand for CGMs, real-world data from Abbott suggests the opposite—use of FreeStyle Libre increased among GLP‑1 users, making the devices a supportive partner in managing glucose changes driven by new medications .
At the same time, the broader wearable market—encompassing smartwatches, rings, and heart health bands—is capitalizing on the wellness wave. In 2025, the global health-tech segment is projected to expand rapidly, driven in large part by men seeking tools for early detection of conditions such as heart issues, sleep disorders, and metabolic imbalances. Products like the Apple Watch, Oura Ring, and Garmin Forerunner continue to attract users focused on tracking exercise, cardiovascular health, and recovery metrics—areas that pair well with GLP‑1-induced lifestyle shifts.
Industry observers note that GLP‑1 treatments and wearable health tracking form a natural synergy. As fitness platforms and telehealth providers emphasize personalized care, gyms and clinics are integrating CGMs, hormone trackers, sleep monitors, and nutrition analytics into holistic programs—catering to men striving for fitness, fat loss, and longevity goals. This growth strategy repositions traditional wristbands and apps as integral components in medicalized health journeys.
Experts caution, however, that while data access empowers individuals, it also carries privacy and interpretation risks. Clinicians stress that technology should supplement—not supplant—professional guidance, and that continuous tracking can sometimes foster anxiety rather than insight.
Overall, the emerging trend among men—backed by record CGM sales and expanding wearable markets—signals a new era of self-directed health management. Instead of isolated fitness fads, consumers are embracing integrated systems that monitor glucose, hormones, sleep, and performance. With GLP‑1s accelerating interest, health-tracking tech is morphing into foundational infrastructure for holistic wellness.